China’s Approach to Treat Alzhiemer’s
China has approved the world’s first multi-targeting and carbohydrate-based drug GV-971 for Alzheimer’s disease. China has the highest Alzheimer’s affected population in the world.
GV-971
- It has been extracted from brown algae and can treat mild to moderate forms of the disease and improve cognition.
- This is the only drug out of more than 320 developed by pharmaceutical companies around the globe to survive clinical trials for treating Alzheimer’s.
- The medicine can be taken orally by the patients.
About Alzheimer’s
- It is a progressive brain disorder that typically affects people older than 65. The disease destroys brain cells and ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 IISc Develops Light-Charged Supercapacitor Technology
- 2 New Nanomaterial Tackles Heavy Metal Contamination
- 3 INCOIS Unveils ‘Integrated Ocean Energy Atlas’
- 4 IISc Develops Brain-Like AI Computing Platform
- 5 India Launches Three Indigenous Supercomputers
- 6 Indigenous Light Tank 'Zorawar'
- 7 ABHED: India’s Cutting-Edge Bulletproof Jacket
- 8 India’s Venus Orbiter Mission
- 9 Thermal Imaging Operations by ISRO’s EOS-08 Satellite
- 10 2024 PT5: A Temporary “Mini-Moon” of Earth
